Zhao XY, Pei XY, Chang YJ, Yu XX, et al. First-line Therapy With Donor-derived Human Cytomegalovirus (HCMV)-specific T Cells Reduces Persistent HCMV Infection by Promoting Antiviral Immunity After Allogenic Stem Cell Transplantation. Clin Infect Dis 2020;70:1429-1437.
PMID: 31067570